Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Ionis Pharmaceuticals, Inc. company logo
Ionis Pharmaceuticals, Inc. logo

Ionis Pharmaceuticals, Inc. (IONS)

Summary

As of today, IONS price is $71.20, down -0.17% in the most recent trading session on
IONS price is currently -17.92% below its historical high of $86.74 set on
IONS current market cap is $12B, up +121.66% over the past 365 days
IONS PE ratio is unknown
IONS current annual revenue is $943.71M, up +33.83% year-over-year
The next earnings release for IONS is on

Profile

Company profile for Ionis Pharmaceuticals, Inc. (IONS)
MetricValue
Full NameIonis Pharmaceuticals, Inc.
TickerNASDAQ: IONS
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
IndexesNot included
Websiteionis.com
Employees1,069

Key Metrics

Ionis Pharmaceuticals, Inc. Key Details
MetricDateValue
Price$71.20
Price, 1D Change-0.17%
Market Cap$12B
-
PE Ratio-
Beta0.70
Revenue$944M
Revenue, 1Y Change+33.83%
EPS-$2.38
EPS, 1Y Change+21.49%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Ionis Pharmaceuticals, Inc. chart

Events

Ionis Pharmaceuticals, Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeISIS
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

IONS Estimates
MetricDateValue
EPS-$2.38
EPS EstimateN/A-$3.24
EPS Est. ChangeN/A-36.06%
Revenue$943.71M
Revenue EstimateN/A$827.69M
Revenue Est. ChangeN/A-12.29%
Current Price$71.20
Price Target-$96.50
Price Tgt. Change-+35.53%

🔒 Log In To Unlock Full Data

EPS

IONS EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$2.54-$3.04-19.31%
-$1.66-$2.38-43.17%
-$3.24N/A-36.06%
-$0.86N/A+63.78%
IONS EPS reported versus estimate values chart

Revenue

IONS revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$620.13M$705.14M+13.71%
$897.47M$943.71M+5.15%
$827.69MN/A-12.29%
$1.36BN/A+44.50%
IONS revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

IONS Performance
MetricDateValue
Price, 1Y+117.54%
Price, 3Y+100.00%
Market Cap, 1Y+121.66%
Market Cap, 3Y+126.61%
Revenue, 1Y+33.83%
Revenue, 3Y+60.67%
EPS, 1Y+21.49%
EPS, 3Y-25.35%

🔒 Log In To Unlock Full Data

Technical Indicators

IONS Technical Indicators
MetricDateValue
Current Price$71.20
SMA 200$64.42
SMA 200 vs Price-9.53%
SMA 50$79.93
SMA 50 vs Price+12.26%
Beta0.70
ATR$2.44
14-Day RSI32.08
10-Day Volatility24.38%
1-Year Volatility50.83%

Dividends

IONS Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
$0.00
0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

IONS Income & Profitability
MetricDateValue
Revenue$943.71M
EPS-$2.38
Gross Profit$928.00M
Gross Margin98.31%
Operating Profit-$382.00M
Operating Margin-40.47%
Net Income-$381.39M
Net Margin-40.36%
EBITDA-$358.99M

🔒 Log In To Unlock Full Data

Financial Health

IONS Financial Health
MetricDateValue
Debt To Equity5.24
1.95
1.94
-
2
1.64

Valuations

IONS Valuations
MetricDateValue
PE Ratio-
12.22
23.58
-31.90
N/A-

Balance Sheet

IONS Balance Sheet
MetricDateValue
Book Value$489.09M
$2.68B
$3.52B
$2.99B
$3.03B
$1.53B
Total Debt$2.61B
$1.18B
$28.08M

Expenses

IONS Expenses
MetricDateValue
$1.33B
$1.31B
$28.36M
$0.00
$22.69M
$0.00
$1.79M

Cash Flow

IONS Cash Flow
MetricDateValue
-$268.58M
-$277.78M
$675.84M
Capex$57.08M
-$325.67M

Recent analyst updates

IONS Recent analyst updates
MetricDateValue
Leerink Partners→
Piper Sandler→
Stifel→
Needham→
Piper Sandler→
Wells Fargo→
RBC Capital→
Leerink Partners→
B of A Securities→
HC Wainwright & Co.→

Analyst sentiment

Sentiment over the past month
IONS analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
IONS institutional ownership distribution chart

Screeners with IONS

FAQ

  • What is the ticker symbol for Ionis Pharmaceuticals, Inc.?

    The ticker symbol for Ionis Pharmaceuticals, Inc. is NASDAQ:IONS

  • Does Ionis Pharmaceuticals, Inc. pay dividends?

    No, Ionis Pharmaceuticals, Inc. does not pay dividends

  • What sector is Ionis Pharmaceuticals, Inc. in?

    Ionis Pharmaceuticals, Inc. is in the Healthcare sector

  • What industry is Ionis Pharmaceuticals, Inc. in?

    Ionis Pharmaceuticals, Inc. is in the Biotechnology industry

  • What country is Ionis Pharmaceuticals, Inc. based in?

    Ionis Pharmaceuticals, Inc. is headquartered in United States

  • When did Ionis Pharmaceuticals, Inc. go public?

    Ionis Pharmaceuticals, Inc. initial public offering (IPO) was on May 17, 1991

  • Is Ionis Pharmaceuticals, Inc. in the S&P 500?

    No, Ionis Pharmaceuticals, Inc. is not included in the S&P 500 index

  • Is Ionis Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Ionis Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

  • Is Ionis Pharmaceuticals, Inc. in the Dow Jones?

    No, Ionis Pharmaceuticals, Inc. is not included in the Dow Jones index

  • When was Ionis Pharmaceuticals, Inc. last earnings report?

    Ionis Pharmaceuticals, Inc.'s most recent earnings report was on February 25, 2026

  • When does Ionis Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Ionis Pharmaceuticals, Inc. is May 6, 2026

Data Sources & References

  1. IONS Official Website www.ionis.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/874015/000087401526000115/0000874015-26-000115-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/874015/000087401526000115/0000874015-26-000115-index.htm
  4. IONS Profile on Yahoo Finance finance.yahoo.com/quote/IONS
  5. IONS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ions